Eli Lilly to spend up to $27 billion in new domestic plants amid Trump tariff threat

Drugmaker Eli Lilly plans to invest up to $27 billion to build four new pharmaceutical manufacturing sites in the U.S., the company announced Wednesday, a move that comes as President Trump is threatening import tariffs on pharmaceuticals. The company said three of the future U.S. sites will focus on manufacturing active pharmaceutical ingredients. The fourth...